Press releasePRNewswire
T. Rowe Price Emerging Markets Equity Research ETF
TEMR · ETF
$26.31+$0.1089 (+0.42%)TodayMarket closed ·
Prev close $26.20
About TEMR
- Issuer
- T. Rowe Price
- Expense ratio
- 0.4%
- Assets under management
- $23.00M
- Inception
- Mar 11, 2026
- Asset class
- Equity
- Website
- troweprice.com
TEMR key statistics
- Price-earnings ratio
- 0.00
- Average volume
- 519
- Volume
- 144
- Open price
- $26.33
- High today
- $26.31
- Low today
- $26.31
- 52 Week high
- $30.25
- 52 Week low
- $23.42
T. Rowe Price Emerging Markets Equity Research ETF (TEMR) at a glance
As of Oct 23, 2026, T. Rowe Price Emerging Markets Equity Research ETF (TEMR) shares are priced at $26.31, giving the company a price-to-earnings ratio of 0.00.
Volume so far is 144 shares, below the average of 519 shares a day.
Over the past year T. Rowe Price Emerging Markets Equity Research ETF has ranged from $23.42 to $30.25, and now sits 42% of the way up that range.
TEMR news
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.